| 产品描述: | Eribulin Mesylate (E7389, B-1939, ER-086526,E7389 mesylate) 是海洋天然产物软海绵素 B 的类似物,是一种非紫杉烷完全合成的 微管 (microtubule)抑制剂 |
| 靶点: |
microtubule;Apoptosis;Others;MicrotubuleAssociated |
| 体外研究: |
Eribulin Mesylate (1-100 nM; 72 h) inhibits cells proliferation of LM8 and Dunn cells. Eribulin Mesylate (10-50 nM; 12-72 h) increases early apoptosis significantly in LM8 cells. Eribulin Mesylate (10-50 nM; 12-72 h) induces G2/M arrest by 12 h treatment with at the dose of 50 nM, but not by long-term treatment (72 h) with 10 nM in LM8 cells. Eribulin Mesylate (1-10 nM; 16 h) induces morphological change and suppresses cell migration in a low concentration in LM8 cells |
| 体内研究: |
Eribulin Mesylate reduces primary tumor growth and lung metastasis of osteosarcoma in mice |
| 细胞实验: |
Cell lines: LM8 cells, Dunn cells Concentrations: 10 nM, 50 nM Incubation Time: 72 h Method: LM8 cells and Dunn cells are incubated with 0 nM, 10 nM, or 50 nM eribulin Mesylate for 12 h, 24 h, 48 h, or 72 h. And then cell proliferation, cell cycle and apoptosis are detected by flow cytometry analysis and immunofluorescence. |
| 动物实验: |
Animal Models: 4-week-old C3H/HeN mice inoculated with LM8 cells Dosages: 1 mg/kg Administration: I.v. |
| 参考文献: |
1. Sarika Jain, Linda T Vahdat. Eribulin mesylate. Clin Cancer Res. 2011 Nov 1;17(21):6615-22. 2. Watanabe K, et al. Low-dose eribulin reduces lung metastasis of osteosarcoma in vitro and in vivo. Oncotarget. 2019 Jan 4;10(2):161-174. |
| 溶解性: |
10 mM in DMSO |
| 保存条件: |
-20℃ |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.211 ml |
6.053 ml |
12.107 ml |
| 5 mM |
0.242 ml |
1.211 ml |
2.421 ml |
| 10 mM |
0.121 ml |
0.605 ml |
1.211 ml |
| 50 mM |
0.024 ml |
0.121 ml |
0.242 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |